Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577678 | PMC |
| http://dx.doi.org/10.1097/CM9.0000000000001743 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recommendations of the Moroccan Society of Rheumatology (SMR) for Diagnostic Management of Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA).
Mediterr J Rheumatol
September 2023
Department of Rheumatology A, El Ayachi Hospital, Ibn Sina University Hospital, Salé, Morocco.
In 2017, the Moroccan Society of Rheumatology (SMR) issued guidelines for the treatment of severe ankylosing spondylitis. The emergence of new therapeutic classes, the update of international guidelines for axial SpA and psoriatic arthritis, and the diagnostic and therapeutic challenges encountered by rheumatologists has led to the development of recent SMR guidelines for the management of SpA patients. A group-work included rheumatologists, specialists in physical medicine and rehabilitation, and epidemiologists from various sectors was tasked with writing these recommendations based on a literature review, then adapting them to the national context.
View Article and Find Full Text PDFCharacteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases.
Cureus
May 2023
Rheumatology, Ezarri Hospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Article Synopsis
- The study investigated characteristics of late-onset spondyloarthritis (SpA) in patients over 45 years old, comparing them to those with early-onset SpA aged 45 or younger.
- Data were collected from the Moroccan registry of biological therapies, involving 194 patients, with 31 classified as having late-onset SpA.
- Key findings included that late-onset SpA patients had significantly more tender and swollen joints, higher rates of depression and fibromyalgia, but lower occurrences of coxitis compared to early-onset patients.
Improvement of clinical and radiological manifestations of coxitis in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitor golimumab: Results of a 24-Month prospective observation study (GO-COX Study).
Int J Rheum Dis
July 2023
MSD Pharmaceuticals LLC, Moscow, Russia.
Aim: The hip joint is the most commonly affected non-axial joint in ankylosing spondylitis (AS). Data on the effects of tumor necrosis factor-α inhibitors (TNFi) in AS patients with coxitis are limited. The aim of this study was evaluation of coxitis treated with the TNFi golimumab in real-world settings.
View Article and Find Full Text PDFPredictors factors of atlanto-axial subluxation in Tunisian patients with rheumatoid arthritis.
Musculoskeletal Care
September 2023
Department of Rheumatology, Kassab Institute of Orthopaedics, La Mannouba, Tunisia.
Background: The aim of this study was to describe clinical and imaging features of atlantoaxial subluxation (AAS) and the associated risk factors in patients with rheumatoid arthritis (RA).
Methods: We conducted a retrospective and comparative study including 51 RA patients with AAS and 51 RA patients without AAS. Atlantoaxial subluxation was defined by the presence of an anterior C1C2 diastasis on the cervical spine radiograph in hyperflexion and/or an anterior, posterior, lateral or rotatory C1C2 dislocation on MRI with/without inflammatory signal.
Association between Rheumatic Disease Comorbidity Index and factors of poor prognosis in a cohort of 280 patients with rheumatoid arthritis.
BMC Rheumatol
December 2022
Rheumatology Department, Charles Nicolle Hospital, 1007, Tunis, Tunisia.
Background: Rheumatoid arthritis (RA) is commonly associated with higher rates of comorbidities. Recent recommendations highlight screening comorbidities during the disease course because of their impact on patients' ability to function, on disease outcome, but also on treatment choices. Hence the interest of our study that aimed to quantify the impact of comorbidities among RA patients using a validated tool the Rheumatic Disease Comorbidity Index (RDCI) and to explore the association between comorbidities and disease characteristics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!